Showing results (11-20 of 261) with videos related to
Sort By:
Pageof 27
The Prostate|June 4, 2004
A prostate stem cell antigen-derived peptide immunogenic in HLA-A24- prostate cancer patientsSatoko Matsueda, Akihisa Yao, Yuki Ishihara, et al.Oncology Reports|July 6, 2007
Differential levels of human leukocyte antigen-class I, multidrug-resistance 1 and androgen receptor expressions in untreated prostate cancer cells: the robustness of prostate cancerShigenori Homma, Yoshihiro Komohara, Mamoru Harada, et al.Oncology Reports|January 5, 2006
Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patientsYi Wang, Mamoru Harada, Hirohisa Yano, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
In vivo evidence that peptide vaccination can induce HLA-DR-restricted CD4+ T cells reactive to a class I tumor peptideMamoru Harada, Rumi Gohara, Satoko Matsueda, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype allelesSatoko Matsueda, Hiroko Takedatsu, Akihisa Yao, et al.Oncology Reports|November 6, 2007
HLA-G as a target molecule in specific immunotherapy against renal cell carcinomaYoshihiro Komohara, Mamoru Harada, Yuki Ishihara, et al.Oncology Reports|October 5, 2007
New peptides of the polycomb group protein enhancer of zeste homolog 2 with the potential to induce cancer-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ prostate cancer patientsYukoh Itoh, Yoshihiro Komohara, Nobukazu Komatsu, et al.Cellular Immunology|September 12, 2006
Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patientsYi Wang, Yukari Takao, Mamoru Harada, et al.Japanese Journal of Cancer Research : Gann|May 3, 2002
Elevation of serum MAGE-4 protein levels and prediction of hepatocellular carcinogenesis in patients with liver cirrhosisShigeru Yutani, Masatoshi Tanaka, Hajime Mutsumoto, et al.The Prostate|April 19, 2007
Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancerMasanori Noguchi, Akihisa Yao, Mamoru Harada, et al.Pageof 27